SK284480B6 - V polohe 4 halogénované steroidy, spôsob ich prípravy a medziprodukty na túto prípravu, ich použitie ako liečiv a farmaceutické prostriedky, ktoré ich obsahujú - Google Patents

V polohe 4 halogénované steroidy, spôsob ich prípravy a medziprodukty na túto prípravu, ich použitie ako liečiv a farmaceutické prostriedky, ktoré ich obsahujú Download PDF

Info

Publication number
SK284480B6
SK284480B6 SK1362-99A SK136299A SK284480B6 SK 284480 B6 SK284480 B6 SK 284480B6 SK 136299 A SK136299 A SK 136299A SK 284480 B6 SK284480 B6 SK 284480B6
Authority
SK
Slovakia
Prior art keywords
phenyl
group
formula
chloro
compound
Prior art date
Application number
SK1362-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK136299A3 (en
Inventor
Yasmina Bouali
Fran�Ois Nique
Jean-Georges Teutsch
De Velde Patrick Van
Original Assignee
Aventis Pharma S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S. A. filed Critical Aventis Pharma S. A.
Publication of SK136299A3 publication Critical patent/SK136299A3/sk
Publication of SK284480B6 publication Critical patent/SK284480B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1362-99A 1997-04-09 1998-04-08 V polohe 4 halogénované steroidy, spôsob ich prípravy a medziprodukty na túto prípravu, ich použitie ako liečiv a farmaceutické prostriedky, ktoré ich obsahujú SK284480B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704321A FR2761992B1 (fr) 1997-04-09 1997-04-09 Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
PCT/FR1998/000709 WO1998045316A1 (fr) 1997-04-09 1998-04-08 Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
SK136299A3 SK136299A3 (en) 2000-05-16
SK284480B6 true SK284480B6 (sk) 2005-04-01

Family

ID=9505672

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1362-99A SK284480B6 (sk) 1997-04-09 1998-04-08 V polohe 4 halogénované steroidy, spôsob ich prípravy a medziprodukty na túto prípravu, ich použitie ako liečiv a farmaceutické prostriedky, ktoré ich obsahujú

Country Status (31)

Country Link
US (5) US6239121B1 (id)
EP (1) EP0973793B1 (id)
JP (1) JP4347420B2 (id)
KR (1) KR20010006149A (id)
CN (1) CN1259956A (id)
AP (1) AP1137A (id)
AR (1) AR012377A1 (id)
AT (1) ATE220408T1 (id)
AU (1) AU750030B2 (id)
BR (1) BR9809578A (id)
CA (1) CA2285679A1 (id)
DE (1) DE69806473T2 (id)
DK (1) DK0973793T3 (id)
EA (1) EA002116B1 (id)
ES (1) ES2178208T3 (id)
FR (1) FR2761992B1 (id)
HR (1) HRP980196B1 (id)
HU (1) HUP0002457A3 (id)
ID (1) ID22930A (id)
IL (1) IL132202A (id)
NO (1) NO315049B1 (id)
NZ (1) NZ337947A (id)
PL (1) PL190629B1 (id)
PT (1) PT973793E (id)
SK (1) SK284480B6 (id)
TR (1) TR199902507T2 (id)
TW (1) TW505621B (id)
UA (1) UA57073C2 (id)
WO (1) WO1998045316A1 (id)
YU (1) YU51199A (id)
ZA (1) ZA983046B (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2780060B1 (fr) * 1998-06-23 2000-08-04 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
FR2826004B1 (fr) * 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
PL2125827T3 (pl) * 2006-12-29 2011-04-29 Hoffmann La Roche Pochodne azaspiro
US20120046461A1 (en) * 2009-01-23 2012-02-23 Northeastern University Steroidal anti-hormone hybrids
FR2942409B1 (fr) * 2009-02-20 2013-07-26 Natacha Voillot Composition pharmaceutique pour la prevention des avortements a repetition.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
US4676932A (en) * 1984-04-09 1987-06-30 The University Of New Mexico Synthesis of 1-haloestradiols
US4859585A (en) * 1986-04-17 1989-08-22 Trustees Of Tufts College In-vitro methods for identifying compositions which are agonists and antagonists of estrogens

Also Published As

Publication number Publication date
US6462211B1 (en) 2002-10-08
TR199902507T2 (xx) 2000-07-21
YU51199A (sh) 2002-09-19
AU750030B2 (en) 2002-07-11
NZ337947A (en) 2001-04-27
FR2761992A1 (fr) 1998-10-16
ATE220408T1 (de) 2002-07-15
KR20010006149A (ko) 2001-01-26
HRP980196B1 (en) 2003-08-31
IL132202A0 (en) 2001-03-19
EA002116B1 (ru) 2001-12-24
AU7339698A (en) 1998-10-30
EP0973793A1 (fr) 2000-01-26
US6472382B2 (en) 2002-10-29
HUP0002457A1 (hu) 2001-02-28
PT973793E (pt) 2002-11-29
NO994908D0 (no) 1999-10-08
UA57073C2 (uk) 2003-06-16
IL132202A (en) 2004-02-19
EA199900909A1 (ru) 2000-04-24
SK136299A3 (en) 2000-05-16
CA2285679A1 (fr) 1998-10-15
DE69806473T2 (de) 2003-02-13
DE69806473D1 (de) 2002-08-14
US6239121B1 (en) 2001-05-29
PL336116A1 (en) 2000-06-05
HRP980196A2 (en) 1998-12-31
JP4347420B2 (ja) 2009-10-21
ID22930A (id) 1999-12-16
NO994908L (no) 1999-12-07
BR9809578A (pt) 2000-07-04
EP0973793B1 (fr) 2002-07-10
US20010039268A1 (en) 2001-11-08
AR012377A1 (es) 2000-10-18
AP9901656A0 (en) 1999-09-30
US20020040135A1 (en) 2002-04-04
TW505621B (en) 2002-10-11
JP2001518891A (ja) 2001-10-16
PL190629B1 (pl) 2005-12-30
US20010005756A1 (en) 2001-06-28
ES2178208T3 (es) 2002-12-16
FR2761992B1 (fr) 1999-06-11
DK0973793T3 (da) 2002-10-28
ZA983046B (en) 1999-04-09
AP1137A (en) 2003-01-12
NO315049B1 (no) 2003-06-30
WO1998045316A1 (fr) 1998-10-15
US20010008941A1 (en) 2001-07-19
CN1259956A (zh) 2000-07-12
US6399766B2 (en) 2002-06-04
HUP0002457A3 (en) 2002-07-29

Similar Documents

Publication Publication Date Title
SK284480B6 (sk) V polohe 4 halogénované steroidy, spôsob ich prípravy a medziprodukty na túto prípravu, ich použitie ako liečiv a farmaceutické prostriedky, ktoré ich obsahujú
JP4476480B2 (ja) 新規な１１β位が置換された１９−ノルステロイド、それらの製造方法及び中間体、それらの薬剤しての使用並びにそれらを含有する製薬組成物
JP4376319B2 (ja) １１位が置換されたステロイド、それらの製造方法、それらの薬剤としての用途及びそれらを含有する製薬組成物
JP4509380B2 (ja) 新規の１７−ハロゲン化−１９−ノルステロイド、それらの製造方法及び中間体、それらの医薬としての使用並びにそれらを含有する製薬組成物
CZ353499A3 (cs) Nové v poloze 4 halogenové steroidy, způsob jejich přípravy a meziprodukty pro tuto přípravu, jejich použití jakožto léčiv a farmaceutické prostředky, které je obsahují
MXPA99009227A (en) Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same
MXPA00012483A (en) Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
MXPA00004712A (en) NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11&bgr;, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM